ArticleFrontiers in medicine2025
Leveraging digital pathology and AI to transform clinical diagnosis in developing countries.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Mechanistic Insights into Wildlife Cancer and Conservation Strategies Under the One Health Framework.Veterinary sciences · 2026Review
- Smart Lies and Sharp Eyes: Pragmatic Artificial Intelligence for Cancer Pathology: Promise, Pitfalls, and Access Pathways.Cancers · 2026Review
- The scientific African diaspora in the Nordic region: policy perspectives on strengthening Africa-Nordic technology collaboration.Frontiers in research metrics and analytics · 2026Article
- Bridging the digital pathology divide: reciprocal learning between high-resource and low-resource settings.BMJ digital health & AI · 2026Review
- Artificial intelligence-assisted photodynamic diagnosis and photodynamic therapy against cancer.Frontiers in oncology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Computational pathology holds the promise of transforming the field of pathology by enabling faster and more accurate diagnosis and treatment planning. Digital pathology and artificial intelligence (AI) play a pivotal role in this transformation, offering more objective and precise diagnoses, increased efficiency, and the ability to handle large volumes of data. However, several translation barriers must be addressed to realize this potential, especially in developing countries. These barriers include the need for standardization of image acquisition and analysis, the limited availability of large, annotated image datasets, and a lack of computational expertise among pathologists. Overcoming these challenges requires collaboration among pathologists, computer scientists, and other experts, as well as the development of new technologies and algorithms. Despite these advancements, standardization and the creation of extensive annotated datasets remain critical issues. Addressing these barriers through collaborative efforts and technological innovation can significantly improve patient outcomes and reduce healthcare costs, making computational pathology a powerful tool in modern medicine in resource-limited settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.